Introduction Despite evidence of the high prevalence of antibiotic resistant infections in
developing countries, studies on the clinical and economic impact of antibiotic resistance …

Background Identifying risk factors predicting acquisition of resistant Pseudomonas
aeruginosa will aid surveillance and diagnostic initiatives and can be crucial in early and …

Background Increasing rates of resistant and multidrug-resistant (MDR) P. aeruginosa in
hospitalized patients constitute a major public health threat. We present a systematic review …

The rates of multidrug-resistant, extensively drug-resistant and pandrug-resistant isolates
amongst non-fermenting Gram-negative bacilli, particularly Pseudomonas aeruginosa, have …

ABSTRACT A systematic review and meta-analyses were performed to identify the risk
factors associated with carbapenem-resistant Pseudomonas aeruginosa and to identify …

Objective: To phenotypically evaluate biofilm production by Pseudomonas
aeruginosaclinically isolated from patients with ventilator-associated pneumonia. Methods …

Pseudomonas aeruginosa is the leading cause of nosocomial infections with high mortality
rates owing to the limited therapeutic options for multidrug-resistant Pseudomonas …

This review summarizes recent epidemiology of Gram‐negative infections in selected
countries from Latin American and Caribbean adult intensive care units (ICUs). A systematic …

Candida albicans is an opportunistic pathogen that proliferates in the intestinal tract of
critically ill patients where it continues to be a major cause of infectious-related mortality. The …

Background/purpose Carbapenem-resistant Pseudomonas aeruginosa infections have
been a challenge and issue in hospital settings. However, the clinical impact of P …